Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy-Reference-Cited by-同舟云学术

Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy

Published:2021-11 Issue:5 Volume:162 Page:1404-1412.e2
ISSN:0022-5223
Container-title:The Journal of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:The Journal of Thoracic and Cardiovascular Surgery

Author:

Corsini Erin M.,Foo Wai Chin,Mitchell Kyle G.,Zhou Nicolas,Maru Dipen M.,Ajani Jaffer A.,Hofstetter Wayne L.,Correa Arlene M.,Antonoff Mara B.,Lin Steven H.,Mehran Reza J.,Rajaram Ravi,Rice David C.,Roth Jack A.,Sepesi Boris,Swisher Stephen G.,Vaporciyan Ara A.,Walsh Garrett L.

Funder

University of Texas MD Anderson Cancer Center

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference21 articles.

1. Signet ring cells in esophageal and gastroesophageal junction carcinomas have a more aggressive biological behavior;Nafteux;Ann Surg,2014

2. Prognostic implications of signet ring cell histology in esophageal adenocarcinoma;Yendamuri;Cancer,2013

3. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?;Heger;Ann Surg Oncol,2014

4. Signet ring cells in esophageal adenocarcinoma predict poor response to preoperative chemoradiation;Patel;Ann Thorac Surg,2014

5. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma;Chirieac;Clin Cancer Res,2005

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Signet ring cells and conditional survival after trimodality therapy for esophageal adenocarcinoma;Journal of Surgical Oncology;2024-07-14

2. Indications for neoadjuvant radiation in esophageal adenocarcinoma: Times are changing;JTCVS Techniques;2024-06

3. Chemotherapy Plus Atezolizumab Pre- and Post-Resection in Localized Esophageal or Gastroesophageal Junction Adenocarcinomas: A Phase I/II Single-Arm Study;Cancers;2024-03-31

4. Gastric Extent of Tumor Predicts Peritoneal Metastasis in Siewert II Adenocarcinoma;The Annals of Thoracic Surgery;2024-02

5. Incidence and Impact of Preoperative Hiatal Hernia in Patients with Esophageal Carcinoma Undergoing Curative Surgical Resection;Journal of Gastrointestinal Surgery;2023-12-01